Оценка использования ксеникала в лечении пациентов с ожирением в условиях амбулаторной практики в г. Москве

1. Дедов И. И., Мельниченко Г. А. Ожирение. М.: Мед. информ. агентство; М.; 2004; 16-23.

2. Ожирение. (клинические очерки). Под редакцией Барановского А.Ю., Ворохобиной Н.В. Диалект; С-Петербург, 2007 ; 9-20.

3. Yanovski S. Z., Yanovski J. A., Obesity. N. Engl. J. Med. 2002; 346:591-602.

4. Bjorntorp P. Obesity. Lancet 1997; 350:423-426.

5. Flegal K. M., Carroll M. D., Kuczmarski R. J., Johnson C. L. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int. J. Obes. Relat. Metabol. Disord. 1998; 22:39-47.

6. Tounian P., Aggoun Y., Dubern B. et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 2001; 385:1400-1404.

7. Desideri G., De Simone M., lughetti L. et al. Early activation of vascular endothelial cells and platelets in obese children. J. Clin. Endocrinol. Metabol. 2005; 90(6):3145-3152.

8. Kahn В. В., Flier J. S. Obesity and insulin resistance. J. Clin. Invest. 2000; 106:473-481.

9. Aronne L. J., Segal R. K. Adiposity and fat distribution outcome measures: assessment and clinical implications. Obes. Res. 2002; 10(l):14S-21S.

10. Bray G. A., Greenway F. L. Current and potential drugs for treatment of obesity. Endocr. Rev. 1999; 20:805-875.

11. Aronne L. J. Therapeutic options for modifying cardiometabolic risk factors. Am. J. Med. 2007; 120(3, suppl.l):S26-S34.

12. Sjostrom L., Rissanen A., Andersen T. et al. Randomised placebocontrolled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet. 1998; 352:167-172.

13. Pinkston M. M., Poston W. S., Reeves R. S. et al. Does metabolic syndrome mitigate weight loss in overweight Mexican American women treated for 1-year with orlistat and lifestyle modification? Eat Weight Disord. 2006; 11(1): e35-e41.

14. Richelsen В., Tonstad S., Rossner S. et al. Effect of orlistat on weight regain and cardiovascular risk factors following a verylowenergy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study. Diabet. Care 2007; 30(l): 27-32.